To see Role of Ajmodadi Churna in rheumatoid Arthritis

clinical evaluation of ama and agni in amavata w.s.r. to rheumatoid profile - CEOAAARP

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013721

Enrollment

Registered

2018-05-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Ajmodadi Churna In Amavata: Ajmoda Apium Graveolus) 1part Vidang(Embelia Ribes) 1 Part Saindhav( Rock Salt) 1 Part Devdaru ( Cedrus Deodara) 1Part Chitraka( Plumbago Zeylanica) 1 Part

Eligibility

Inclusion criteria

Inclusion criteria: Patient of age group 25 to 60 years Patients having classical symptoms of Amavata Patients fulfilling the diagnostic criteria American rheumatological Association 1988 Both sero positive and sero negative cases will be included

Exclusion criteria

Exclusion criteria: Chronocity for more than 10 years Patients of Amavata having any severe deformity patients of Amavata having any other systemic disease like HTN diabetes tuberculosis and any major complication

Design outcomes

Primary

Measure	Time frame
Work is yet to be startedTimepoint: Work is due to be finished june 2019	—

Secondary

Measure	Time frame
work is yet to be startedTimepoint: work is due to be finished june 2019	—

Countries

India

Contacts

Public ContactJyotsna Awasthi

Rishikul Campus Uttarakhand Ayurved University Haridwar

jamsawas1990@gmail.com9870864564

Outcome results